148 related articles for article (PubMed ID: 10763957)
1. Successful interferon therapy reverses enhanced hepatic iron accumulation and lipid peroxidation in chronic hepatitis C.
Kageyama F; Kobayashi Y; Kawasaki T; Toyokuni S; Uchida K; Nakamura H
Am J Gastroenterol; 2000 Apr; 95(4):1041-50. PubMed ID: 10763957
[TBL] [Abstract][Full Text] [Related]
2. Role of transferrin receptor 2 in hepatic accumulation of iron in patients with chronic hepatitis C.
Mifuji R; Kobayashi Y; Ma N; Qiang QL; Urawa N; Horiike S; Iwasa M; Kaito M; Malavasi F; Adachi Y
J Gastroenterol Hepatol; 2006 Jan; 21(1 Pt 1):144-51. PubMed ID: 16706826
[TBL] [Abstract][Full Text] [Related]
3. Failure to respond to interferon-alpha 2a therapy is associated with increased hepatic iron levels in patients with chronic hepatitis C.
Kageyama F; Kobayashi Y; Murohisa G; Shimizu E; Suzuki F; Kikuyama M; Souda K; Kawasaki T; Nakamura H
Biol Trace Elem Res; 1998; 64(1-3):185-96. PubMed ID: 9845473
[TBL] [Abstract][Full Text] [Related]
4. Enhanced hepatic lipid peroxidation in patients with primary biliary cirrhosis.
Kawamura K; Kobayashi Y; Kageyama F; Kawasaki T; Nagasawa M; Toyokuni S; Uchida K; Nakamura H
Am J Gastroenterol; 2000 Dec; 95(12):3596-601. PubMed ID: 11151898
[TBL] [Abstract][Full Text] [Related]
5. Iron reduction before and during interferon therapy of chronic hepatitis C: results of a multicenter, randomized, controlled trial.
Fontana RJ; Israel J; LeClair P; Banner BF; Tortorelli K; Grace N; Levine RA; Fiarman G; Thiim M; Tavill AS; Bonkovsky HL
Hepatology; 2000 Mar; 31(3):730-6. PubMed ID: 10706565
[TBL] [Abstract][Full Text] [Related]
6. Hepatic oxidative DNA damage correlates with iron overload in chronic hepatitis C patients.
Fujita N; Horiike S; Sugimoto R; Tanaka H; Iwasa M; Kobayashi Y; Hasegawa K; Ma N; Kawanishi S; Adachi Y; Kaito M
Free Radic Biol Med; 2007 Feb; 42(3):353-62. PubMed ID: 17210448
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical detection of 4-hydroxy-2-nonenal-modified-protein adducts in human alcoholic liver diseases.
Ohhira M; Ohtake T; Matsumoto A; Saito H; Ikuta K; Fujimoto Y; Ono M; Toyokuni S; Kohgo Y
Alcohol Clin Exp Res; 1998 May; 22(S3 Pt 1):145S-149S. PubMed ID: 9622393
[TBL] [Abstract][Full Text] [Related]
8. Hepatic iron concentration does not predict response to standard and pegylated-IFN/ribavirin therapy in patients with chronic hepatitis C.
Hofer H; Osterreicher C; Jessner W; Penz M; Steindl-Munda P; Wrba F; Ferenci P
J Hepatol; 2004 Jun; 40(6):1018-22. PubMed ID: 15158344
[TBL] [Abstract][Full Text] [Related]
9. Histological change after interferon therapy in chronic hepatitis C in view of iron deposition in the liver.
Kakizaki S; Takagi H; Ichikawa T; Abe T; Yamada T; Suzuki K; Kojima A; Takayama H; Takezawa J; Nagamine T; Mori M
Biol Trace Elem Res; 2000 Feb; 73(2):151-62. PubMed ID: 11049207
[TBL] [Abstract][Full Text] [Related]
10. In situ detection of oxidized n-3 polyunsaturated fatty acids in chronic hepatitis C: correlation with hepatic steatosis.
Kitase A; Hino K; Furutani T; Okuda M; Gondo T; Hidaka I; Hara Y; Yamaguchi Y; Okita K
J Gastroenterol; 2005 Jun; 40(6):617-24. PubMed ID: 16007396
[TBL] [Abstract][Full Text] [Related]
11. In situ detection of lipid peroxidation in chronic hepatitis C: correlation with pathological features.
Paradis V; Mathurin P; Kollinger M; Imbert-Bismut F; Charlotte F; Piton A; Opolon P; Holstege A; Poynard T; Bedossa P
J Clin Pathol; 1997 May; 50(5):401-6. PubMed ID: 9215123
[TBL] [Abstract][Full Text] [Related]
12. Comparison of hepatic oxidative DNA damage in patients with chronic hepatitis B and C.
Fujita N; Sugimoto R; Ma N; Tanaka H; Iwasa M; Kobayashi Y; Kawanishi S; Watanabe S; Kaito M; Takei Y
J Viral Hepat; 2008 Jul; 15(7):498-507. PubMed ID: 18331251
[TBL] [Abstract][Full Text] [Related]
13. Prooxidant-initiated lipid peroxidation in isolated rat hepatocytes: detection of 4-hydroxynonenal- and malondialdehyde-protein adducts.
Hartley DP; Kroll DJ; Petersen DR
Chem Res Toxicol; 1997 Aug; 10(8):895-905. PubMed ID: 9282839
[TBL] [Abstract][Full Text] [Related]
14. Exacerbation of insulin resistance and hepatic steatosis deriving from zinc deficiency in patients with HCV-related chronic liver disease.
Himoto T; Nomura T; Tani J; Miyoshi H; Morishita A; Yoneyama H; Haba R; Masugata H; Masaki T
Biol Trace Elem Res; 2015 Feb; 163(1-2):81-8. PubMed ID: 25413880
[TBL] [Abstract][Full Text] [Related]
15. [The effect of iron depletion on the response to interferon treatment in patients with chronic hepatitis C. Pilot study].
Ortiz V; Olaso V; López Viedma B; Córdoba J; Molina JM; Lainez B; Pastor M; Berenguer J
Gastroenterol Hepatol; 1999 Mar; 22(3):122-6. PubMed ID: 10228321
[TBL] [Abstract][Full Text] [Related]
16. Semiquantitative and qualitative assessment of hepatic iron in patients with chronic viral hepatitis: relation with grading, staging and haemochromatosis mutations.
Vergani A; Bovo G; Trombini P; Caronni N; Arosio C; Malosio I; Fossati L; Roffi L; Piperno A
Ital J Gastroenterol Hepatol; 1999; 31(5):395-400. PubMed ID: 10470600
[TBL] [Abstract][Full Text] [Related]
17. Hepatic iron stainings in chronic hepatitis C patients with low HCV RNA levels: a predictive marker for IFN therapy.
Akiyoshi F; Sata M; Uchimura Y; Suzuki H; Tanikawa K
Am J Gastroenterol; 1997 Sep; 92(9):1463-6. PubMed ID: 9317063
[TBL] [Abstract][Full Text] [Related]
18. Increased lipid peroxidation in patients with non-alcoholic fatty liver disease and chronic hepatitis C as measured by the plasma level of 8-isoprostane.
Konishi M; Iwasa M; Araki J; Kobayashi Y; Katsuki A; Sumida Y; Nakagawa N; Kojima Y; Watanabe S; Adachi Y; Kaito M
J Gastroenterol Hepatol; 2006 Dec; 21(12):1821-5. PubMed ID: 17074020
[TBL] [Abstract][Full Text] [Related]
19. The effect of interferon and desferrioxamine on serum ferritin and hepatic iron concentrations in chronic hepatitis B.
Bayraktar Y; Saglam F; Temizer A; Uzunalimodlu B; van Thiel DH
Hepatogastroenterology; 1998; 45(24):2322-7. PubMed ID: 9951916
[TBL] [Abstract][Full Text] [Related]
20. Malondialdehyde and 4-hydroxynonenal protein adducts in plasma and liver of rats with iron overload.
Houglum K; Filip M; Witztum JL; Chojkier M
J Clin Invest; 1990 Dec; 86(6):1991-8. PubMed ID: 2123889
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]